Search research articles
Contact Us
Filters
Showing results (61-70 of 66) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 66 results.
The Journal of Dermatological Treatment
|
August 15, 2023
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years
Cataldo Patruno, Gabriella Fabbrocini, Giuseppe Lauletta, et al.
Clinical and Experimental Dermatology
|
October 30, 2025
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational Study
Giuseppe Lauletta, Cataldo Patruno, Luca Potestio, et al.
International Journal of Dermatology
|
August 21, 2025
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study
Luca Potestio, Cataldo Patruno, Marika Del Gaudio, et al.
Clinical and Experimental Dermatology
|
June 27, 2025
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World Study
Francesca Barei, Stefano Macchi, Paolo Calzari, et al.
Clinical and Experimental Dermatology
|
April 15, 2026
Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN Study
Marina Talamonti, Edoardo Mortato, Alessandra Narcisi, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
October 4, 2019
Italian Guidelines in diagnosis and treatment of alopecia areata
Alfredo Rossi, Marta Muscianese, Bianca M Piraccini, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 66) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 66 results.
The Journal of Dermatological Treatment
|
August 15, 2023
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years
Cataldo Patruno, Gabriella Fabbrocini, Giuseppe Lauletta, et al.
Clinical and Experimental Dermatology
|
October 30, 2025
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational Study
Giuseppe Lauletta, Cataldo Patruno, Luca Potestio, et al.
International Journal of Dermatology
|
August 21, 2025
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study
Luca Potestio, Cataldo Patruno, Marika Del Gaudio, et al.
Clinical and Experimental Dermatology
|
June 27, 2025
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World Study
Francesca Barei, Stefano Macchi, Paolo Calzari, et al.
Clinical and Experimental Dermatology
|
April 15, 2026
Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN Study
Marina Talamonti, Edoardo Mortato, Alessandra Narcisi, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
October 4, 2019
Italian Guidelines in diagnosis and treatment of alopecia areata
Alfredo Rossi, Marta Muscianese, Bianca M Piraccini, et al.
Page
of 7